Delivery Order SPE2DB22D2206-SPE2DB23FGA27
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,954.52, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This contract award, valued at $10,012.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award, valued at $56,988.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, is for the supply of BIKTARVY 50-200-25 MG TABLET pharmaceutical products. The contract does not have a set-aside designation, indicating the award was made through...
- This federal contract award, valued at $27,796.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has a firm fixed-price pricing type with an ultimate completion date of November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This federal contract award, valued at $55,028.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the procurement of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support...
- This federal contract award, valued at $36,548.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has a performance period extending through May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $6,738.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award, valued at $4,644.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $45,048.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which runs through November 2026. The contract covers the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication,...
- This federal contract award, valued at $42,465.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FGA27Delivery Order
This federal contract award, valued at $96,681.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of BIKTARVY 50-200-25 MG TABLET to support military healthcare programs. Amerisourcebergen is a critical vendor for the DLA, providing a comprehensive range of pharmaceutical products, medical supplies, and other medical commodities across various therapeutic areas. This contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $96.7k | 3/7/23 |